Pastāsti draugiem par šo preci:
Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations - Chapman & Hall / CRC Biostatistics Series Avery Mcintosh-Oleksandr Sverdlov
Cena
€ 266,99
Pasūtīts no attālās noliktavas
Paredzamā piegāde . gada 24. nov. - . gada 8. dec.
Ziemassvētku dāvanas var atgriezt līdz 31. janvārim
Saņemiet paziņojumus par jauniem Avery Mcintosh-Oleksandr Sverdlov izdevumiem
Mūsu klienti saka:
Pievienot savam iMusic vēlmju sarakstam
Development of Gene Therapies: Strategic, Scientific, Regulatory, and Access Considerations - Chapman & Hall / CRC Biostatistics Series
Avery Mcintosh-Oleksandr Sverdlov
Development of Gene Therapies: Strategic, Scientific, and Regulatory, and Access Considerations attempts to summarize the current state-of-the-art strategic, scientific, statistical, and regulatory aspects of GTx development.
488 pages, 1 Tables, color; 19 Tables, black and white; 36 Line drawings, color; 1 Line drawings, bl
| Mediji | Grāmatas Hardcover Book (Grāmata ar cieto muguriņu un vāku) |
| Izlaists | 2024. gada 23. maijs |
| ISBN13 | 9781032136554 |
| Izdevēji | Taylor & Francis Ltd |
| Lapas | 458 |
| Izmēri | 150 × 220 × 20 mm · 1,07 kg |
| Valoda | Angļu |
| Redaktors | McIntosh, Avery (Apellis Pharmaceuticals|Novartis, USA) |
| Redaktors | Sverdlov, Oleksandr (Apellis Pharmaceuticals|Novartis, USA) |
